CHINA NUOKANG (NASDAQ:NKBP)

Thursday, September 27, 2012 | Web News
BEIJING, Sept. 27, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the...
Thursday, August 23, 2012 | Web News
Second Quarter 2012 Financial Highlights Revenue was RMB72.9 million ($11.5 million)1, compared to RMB79.5 million in the prior year period;...
Friday, June 15, 2012 | Web News
BEIJING, June 15, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "...
See All Research...
China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) is a leading biopharmaceutical company in China focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. The Company provides a diversified portfolio of products across more than 2,400 hospitals in China. Nuokang's principal products include Baquting(R), China's leading hemocoagulase product by market share, and Aiduo(R), a cardiovascular stress imaging agent. The Company's product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention.

Web site: http://www.nkbp.com

Last updated December 26, 2009


Market Data powered by QuoteMedia. Terms of Use